Vorsitz: S. Blankenberg (Mainz), C. Hengstenberg (Regensburg)
(V851) | Difference in gene expression of macrophages stimulated with atherogenic substances regarding the chromosome 9p21 |
|
M. Graßl, K. Stark, S. Fenk, R. Hoecherl, U. Hubauer, W. Reinhard, B. Kaess, C. Zollbrecht, U. Esslinger, S. Ebert, T. Langmann, C. Hengstenberg (Regensburg) |
(V852) | Genome-wide significant SNPs for Blood Pressure and Hypertension are associated with Myocardial Infarction. Results of the GerMIFS I-III (KORA) |
|
J. Erdmann, P. Linsel-Nitschke, J. Baumert, C. Hengstenberg, C. Gieger, H.-E. Wichmann, A. Peters, H. Schunkert (Lübeck, Neuherberg, Regensburg) |
(V853) | Associations between variations in the TLR4 gene and incident coronary heart disease (CHD) in middle-aged men and women: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002 |
|
M. Karakas, J. Baumert, M. Müller, N. Klopp, B. Thorand, C. Meisinger, C. Herder, W. Koenig (Ulm, Neuherberg, Düsseldorf) |
(V854) | Genome-wide association study identifies a new locus for coronary artery disease on chromosome 10p11.23 |
|
J. Erdmann, C. Willenborg, J. Baumert, C. Hengstenberg, C. Gieger, P. Linsel-Nitschke, H.-E. Wichmann, A. Peters, H. Schunkert (Lübeck, München, Regensburg) |
(V855) | CYP2C19 Genetic Variants and Clinical Outcomes with Clopidogrel: A Collaborative Meta-Analysis |
|
J. L. Mega, T. Simon, J. L. Anderson, K. Bliden, J.-P. Collet, N. Danchin, B. Giusti, P. Gurbel, B. D. Horne, A. Kastrati, G. Montalescot, F.-J. Neumann, L. Shen, D. Sibbing, P. G. Steg, D. Trenk, S. D. Wiviott, M. S. Sabatine (Boston, Murray, Baltimore, Indianapolis, US; Paris, FR; Florence, IT; München, Bad Krozingen) |
(V856) | KIF6 719Arg genetic variant predicts both risk for coronary events and greater response to statin therapy: results from CARE, WOSCOPS, PROSPER and PROVE IT-TIMI 22 studies |
|
O. Iakoubova (Alameda, US) |